Blunted d-amphetamine response in major depressive disorder (MDD).

被引：0
|
作者：
Tremblay, LK
Naranjo, CA
Busto, U
Cardenas, L
机构：
[1] Univ Toronto, Dept Pharmacol, CAMH, SHSC, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychol, CAMH, SHSC, Toronto, ON, Canada
[3] Univ Toronto, Dept Med, CAMH, SHSC, Toronto, ON, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80098-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI98
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [21] Effects of vortioxetine on cognitive symptoms of major depressive disorder (MDD)
    Fava, M.
    Lophaven, S.
    Olsen, C.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 61 - 61
  • [22] Vortioxetine versus citalopram in treating major depressive disorder (MDD)
    Rossi, A.
    Di Tullio, E.
    Prosperini, P.
    Feggi, A.
    Gramaglia, C.
    Zeppegno, P.
    [J]. EUROPEAN PSYCHIATRY, 2017, 41 : S540 - S541
  • [23] Correction to: Neuroimaging Genomics a Predictor of Major Depressive Disorder (MDD)
    Manav Jindal
    Aakash Chhetri
    Abhilash Ludhiadch
    Paramdeep Singh
    Sameer Peer
    Jawahar Singh
    Rahatdeep Singh Brar
    Anjana Munshi
    [J]. Molecular Neurobiology, 2024, 61 : 3441 - 3441
  • [24] Exploring Gender Differences in the Placebo Response to Major Depressive Disorder (MDD) Using Neuroimaging Techniques
    Jahan, Aava
    Dillon, Daniel
    Petibon, Yoann
    Meyer, Ashley
    Normandin, Marc
    Belleau, Emily
    Alpert, Nathaniel
    El Fakhri, Georges
    Hooker, Jacob
    Crowley, David
    Cusin, Cristina
    Pizzagalli, Diego
    Fava, Maurizio
    [J]. BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S171 - S172
  • [25] Association of Rare Variants in ADRA1a with Response to Treatment for Major Depressive Disorder (MDD)
    Lori, Adriana
    Tania, Carillo-Roa
    Binder, Elisabeth B.
    Mayberg, Helen S.
    McGrath, Callie L.
    Mletzko, Tanja C.
    Dunlop, Boadie W.
    Craighead, Edward W.
    Kelley, Mary E.
    Mulle, Jennifer G.
    Cubells, Joseph F.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09)
  • [26] Analysis of Rare Variants in ADRA1a with Response to Treatment for Major Depressive Disorder (MDD)
    Lori, Adriana
    Carillo-Roa, Tania
    Binder, Elisabeth B.
    Mayberg, Helen S.
    McGrath, Callie L.
    Mletzko, Tanja
    Laird, Jordan L.
    Czamara, Darina
    Dunlop, Boadie W.
    Craighead, W. Edward
    Kelley, Mary E.
    Mulle, Jennifer G.
    Nemeroff, Charles B.
    Cubells, Joseph F.
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 225S - 226S
  • [27] Duloxetine versus placebo in patients with major depressive disorder (MDD): assessment of energy and vitality in MDD
    Myers-Oakes, T. M.
    Thase, M. E.
    Meyers, A. L.
    Ahl, J.
    Prakash, A.
    Marangell, L. B.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S425 - S426
  • [28] HYPERTHERMIC RESPONSE TO D-AMPHETAMINE IN DECAPITATED RAT
    WEIS, J
    [J]. LIFE SCIENCES, 1973, 13 (05) : 475 - 484
  • [29] AGGRESSION IN HYPERACTIVE BOYS - RESPONSE TO D-AMPHETAMINE
    AMERY, B
    MINICHIELLO, MD
    BROWN, GL
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1984, 23 (03): : 291 - 294
  • [30] Shuganjieyu capsule for major depressive disorder (MDD) in adults: a systematic review
    Zhang, Xin
    Kang, Deying
    Zhang, Lan
    Peng, Le
    [J]. AGING & MENTAL HEALTH, 2014, 18 (08) : 941 - 953
12345